The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms

被引：47
作者：
Holmstrom, M. O. [1 ,2 ]
Hjortso, M. D. [2 ]
Ahmad, S. M. [2 ]
Met, O. [2 ,3 ]
Martinenaite, E. [2 ]
Riley, C. [1 ]
Straten, P. [2 ]
Svane, I. M. [2 ,3 ]
Hasselbalch, H. C. [1 ]
Andersen, M. H. [2 ,4 ]
机构：
[1] Zealand Univ Hosp, Dept Hematol, Roskilde, Denmark
[2] Univ Copenhagen, Dept Hematol, Ctr Canc Immune Therapy, Herlev Hosp, Herlev, Denmark
[3] Univ Copenhagen, Dept Oncol, Herlev Hosp, Herlev, Denmark
[4] Univ Copenhagen, Dept Immunol & Microbiol, Copenhagen, Denmark
来源：
LEUKEMIA | 2017年 / 31卷 / 02期
关键词：
POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; DISORDERS; JAK2;
D O I：
10.1038/leu.2016.290
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：495 / 498
页数：5
相关论文
共 50 条
  • [1] Thrombosis in Myeloproliferative Neoplasms With JAK2V617F Mutation
    Sun, Tiantian
    Zhang, Lei
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (04) : 374 - 381
  • [2] Underlying mechanisms of the JAK2V617F mutation in the pathogenesis of myeloproliferative neoplasms
    Mullally, A.
    PATHOLOGE, 2016, 37 : 175 - 179
  • [3] JAK2V617F allele burden in patients with myeloproliferative neoplasms
    Alshemmari, Salem H.
    Rajaan, Reshmi
    Ameen, Reem
    Al-Drees, Mohammad A.
    Almosailleakh, Marwa R.
    ANNALS OF HEMATOLOGY, 2014, 93 (05) : 791 - 796
  • [4] The impact of JAK2V617F mutation on Philadelphia-negative myeloproliferative neoplasms
    Sahin, Ezgi
    Yonal-Hindilerden, Ipek
    Hindilerden, Fehmi
    Aday, Aynur
    Nalcaci, Meliha
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (01) : 150 - 165
  • [5] JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms
    Etheridge, S. Leah
    Roh, Michelle E.
    Cosgrove, Megan E.
    Sangkhae, Veena
    Fox, Norma E.
    Chen, Junmei
    Lopez, Jose A.
    Kaushansky, Kenneth
    Hitchcock, Ian S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (06) : 2295 - 2300
  • [6] JAK2V617F-Positive Endothelial Cells Induce Apoptosis and Release JAK2V617F-Positive Microparticles
    Hekimoglu, Hilal
    Toprak, Selin Fulya
    Sozer, Selcuk
    TURKISH JOURNAL OF HEMATOLOGY, 2022, 39 (01) : 13 - 21
  • [7] A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
    Kilpivaara, Outi
    Mukherjee, Semanti
    Schram, Alison M.
    Wadleigh, Martha
    Mullally, Ann
    Ebert, Benjamin L.
    Bass, Adam
    Marubayashi, Sachie
    Heguy, Adriana
    Garcia-Manero, Guillermo
    Kantarjian, Hagop
    Offit, Kenneth
    Stone, Richard M.
    Gilliland, D. Gary
    Klein, Robert J.
    Levine, Ross L.
    NATURE GENETICS, 2009, 41 (04) : 455 - 459
  • [8] Thrombosis in myeloproliferative neoplasia Influence of the mutation JAK2V617F
    Guy, Alexandre
    James, Chloe
    M S-MEDECINE SCIENCES, 2019, 35 (8-9): : 651 - 658
  • [9] Leukocytosis, JAK2V617F Mutation, and Hemostasis in Myeloproliferative Disorders
    Marchetti, Marina
    Falanga, Anna
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2007, 36 (3-4) : 148 - 159
  • [10] Identification of JAK2V617F Mutation on Myeloproliferative Disorders in Medan
    Anggraini, Dwi Rita
    Hidayat
    Sitorus, Mega Sari
    PROCEEDINGS OF THE 1ST PUBLIC HEALTH INTERNATIONAL CONFERENCE (PHICO 2016), 2016, 1
12345